Parent Issue

White Bagging — Medication Distribution Payer Changes

How familiar are you with “white bagging?” Maybe you’ve heard of it but aren’t sure what it is or how it affects your facility. Here’s a quick explanation: white bagging means payers reimburse third-party pharmacies, which then distribute the medications to outpatient medical providers, removing your ability to make changes to the patients’ medication.

HRSA Orders Drug Companies to Resume Discounts to 340B Contract Pharmacies

The Health Resources & Services Administration (HRSA) ordered six pharmaceutical companies to resume payments to contract pharmacies participating in the 340B discount program, stating that their current policies have resulted in overcharges and are in direct violation of the 340B statute. The letters were sent to Eli Lilly, Sanofi, AstraZeneca, Novartis, United Therapeutics, and Novo Nordisk. 

CHA Issues Summary of Final Rule on Medicaid Drug Rebate Program, Value-Based Purchasing Arrangements

CHA has issued a detailed summary, prepared by Health Policy Alternatives, Inc., of the final rule issued by the Centers for Medicare & Medicaid Services that makes changes to the Medicaid Drug Rebate Program, drug utilization review, and third-party liability regulations, and revises requirements for value-based purchasing (VBP) agreements between states and manufacturers for drugs covered by Medicaid.